Novartis P/E Ratio
NOVARTIND • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
25.75
High Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
25.75
Current Price
₹1001.70
EPS (TTM)
₹40.87
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
47.65
Sector Median
25.5
Sector Rank
#11 of 139
Sector Percentile
7.9%
Key P/E Ratio Insights for Novartis
- Stock appears overvalued with PE of 25.75, suggesting caution for new investments
- Trading at discount to sector average PE of 47.65
Related Pages for Novartis
Additional stock information and data for NOVARTIND
Sector P/E Ratio Comparison
Comparing Novartis with other companies in Healthcare sector
Sector Average
47.65
Sector Median
25.5
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.83 | ₹31 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.53 | ₹1,133 | Low |
| Amwill Health Care | AMWILL | 5.67 | ₹64 | Low |
| Brooks Laboratories | BROOKS | 6.14 | ₹157 | Low |
| Medicamen Organics | MEDIORG | 6.4 | ₹27 | Low |
| Zenith Drugs | ZENITHDRUG | 6.83 | ₹69 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.15 | ₹2,100 | Low |
| Galaxy Medicare | GML | 7.41 | ₹26 | Low |
| Vasundhara Rasayans | VRL | 9.35 | ₹34 | Low |